Latest Articles
SIRT7 facilitates endometrial cancer progression by regulating PTEN stability in an estrogen-dependent manner - Nature.com
SIRT7 facilitates endometrial cancer progression by regulating PTEN stability in an estrogen-dependent manner Nature.com
Published: March 27, 2025, 6:35 a.m.
Dr Mirza on Long-Term Response Data for Dostarlimab Plus Chemo in Advanced Endometrial Cancer - OncLive
Dr Mirza on Long-Term Response Data for Dostarlimab Plus Chemo in Advanced Endometrial Cancer OncLive
Published: March 26, 2025, 10:21 p.m.
Humacyte to raise $50M; Acrivon to focus on prexasertib in endometrial cancer - Endpoints News
Humacyte to raise $50M; Acrivon to focus on prexasertib in endometrial cancer Endpoints News
Published: March 26, 2025, 2:10 p.m.
Promising Phase 2 Results for ACR-368 in Endometrial Cancer Justify Buy Rating - TipRanks
Promising Phase 2 Results for ACR-368 in Endometrial Cancer Justify Buy Rating TipRanks
Published: March 26, 2025, 10:20 a.m.
Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit - AboutLawsuits.com
Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit AboutLawsuits.com
Published: March 25, 2025, 4 p.m.
Tampon-Based Test Detects Endometrial Cancer Using Vaginal Fluid Biomarkers - Medscape
Tampon-Based Test Detects Endometrial Cancer Using Vaginal Fluid Biomarkers Medscape
Published: March 25, 2025, 5:52 a.m.
Tampon Test Detects Endometrial Cancer - Medscape
Tampon Test Detects Endometrial Cancer Medscape
Published: March 25, 2025, 5:52 a.m.
University of Cincinnati Cancer Center Reports Metformin Enhances Treatment in ER-Positive Endometrial Cancer - Hoodline
University of Cincinnati Cancer Center Reports Metformin Enhances Treatment in ER-Positive Endometrial Cancer Hoodline
Published: March 24, 2025, 7:46 p.m.
Add-on metformin promising in ER-positive endometrial cancer - University of Cincinnati
Add-on metformin promising in ER-positive endometrial cancer University of Cincinnati
Published: March 24, 2025, 5:05 p.m.
Exploratory Post Hoc Analysis of DUO-E Reveals Olaparib’s Benefit in Endometrial Cancer Subsets - The ASCO Post
Exploratory Post Hoc Analysis of DUO-E Reveals Olaparib’s Benefit in Endometrial Cancer Subsets The ASCO Post
Published: March 24, 2025, 2:03 p.m.
Link copied to clipboard!